IRF4与NF-κB驱动成人T细胞白血病/淋巴瘤的前馈调控环路
该研究在成人T细胞白血病/淋巴瘤(ATL)细胞中揭示了IRF4与NF-κB两个致癌转录因子驱动的转录调控网络。原发ATL样本中IRF4表达高于正常T细胞,IRF4结合区域富集于超级增强子,NF-κB共占IRF4结合调控元件形成前馈环路,协同调控MYC、CCR4和BIRC3等超级增强子相关癌基因,抑制BIRC3可抑制ATL细胞生长。
要点
- ATL细胞中IRF4表达高于正常T细胞,IRF4结合区域富集于超级增强子。
- IRF4与NF-κB共占调控元件形成前馈环路,协同调控T细胞功能与发育相关基因。
- BIRC3是IRF4-NF-κB网络下游关键效应分子,遗传抑制BIRC3可抑制ATL细胞生长。
核心结论
- IRF4与NF-κB在ATL细胞中形成前馈调控环路,协同调控包括MYC、CCR4和BIRC3在内的超级增强子相关癌基因。
- BIRC3作为该网络下游关键效应分子,其遗传抑制可诱导ATL细胞生长抑制。
研究设计与样本
- 研究对原发ATL样本进行基因表达谱分析,比较IRF4在ATL细胞与正常T细胞中的表达。
- 采用染色质免疫沉淀测序(ChIP-seq)分析IRF4结合区域在超级增强子与典型增强子中的分布。
- 通过遗传抑制BIRC3评估其对ATL细胞生长的影响。
主要发现
- 原发ATL样本中IRF4基因在ATL细胞中的表达高于正常T细胞。
- ChIP-seq显示IRF4结合区域在超级增强子中比在典型增强子中更常见。
- NF-κB共占IRF4结合的调控元件,形成连贯的前馈环路,协同调控T细胞功能与发育相关基因。
- IRF4和NF-κB调控ATL细胞中多个与超级增强子相关的癌基因,包括MYC、CCR4和BIRC3。
- 遗传抑制BIRC3可诱导ATL细胞生长抑制,提示其作为IRF4-NF-κB转录网络下游关键效应分子的作用。
临床怎么用
- IRF4-NF-κB前馈环路及其下游效应分子BIRC3可作为ATL潜在治疗靶点。
- BIRC3抑制可抑制ATL细胞生长,提示靶向BIRC3可能具有治疗价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive hematological malignancy derived from mature CD4+ T-lymphocytes. Here, we demonstrate the transcriptional regulatory network driven by 2 oncogenic transcription factors, IRF4 and NF-κB, in ATL cells. Gene expression profiling of primary ATL samples demonstrated that the IRF4 gene was more highly expressed in ATL cells than in normal T cells. Chromatin immunoprecipitation sequencing analysis revealed that IRF4-bound regions were more frequently found in super-enhancers than in typical enhancers. NF-κB was found to co-occupy IRF4-bound regulatory elements and formed a coherent feed-forward loop to coordinately regulate genes involved in T-cell functions and development. Importantly, IRF4 and NF-κB regulated several cancer genes associated with super-enhancers in ATL cells, including MYC, CCR4, and BIRC3. Genetic inhibition of BIRC3 induced growth inhibition in ATL cells, implicating its role as a critical effector molecule downstream of the IRF4-NF-κB transcriptional network.
引用
- Wong RWJ, Tan TK, Amanda S, et al. Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma. Blood. 2020. PMID: 31972002. doi:10.1182/blood.2019002639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。